JAFL
TNGX icon

Jay A. Fishman Ltd’s Tango Therapeutics TNGX Stock Holding History

Jay A. Fishman Ltd’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,000
Closed -$163K – 92
2024
Q2 		$163K Sell
19,000
-5,000
-21% -$38.6K 0.02% 85
2024
Q1 		$191K Buy
24,000
+10,000
+71% +$107K 0.02% 87
2023
Q4 		$139K Hold
14,000
– – 0.02% 90
2023
Q3 		$158K Sell
14,000
-6,000
-30% -$36.6K 0.02% 94
2023
Q2 		$66.4K Buy
20,000
+10,000
+100% +$36K 0.01% 97
2023
Q1 		$39.5K Hold
10,000
– – 0.01% 93
2022
Q4 		$72.5K Buy
+10,000
New +$70.3K 0.01% 96

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Jay A. Fishman Ltd's TNGX Position: Q3 2024 in Review

Jay A. Fishman Ltd sold out of Tango Therapeutics (TNGX) in Q3 2024, closing a stake of 19,000 shares — an estimated $163K sold.

Jay A. Fishman Ltd first reported a position in TNGX in Q4 2022 and held it in 7 quarters. The position peaked at $191K in Q1 2024. 121 funds tracked by Wall St. Rank hold TNGX as of Q3 2024.

  • Jay A. Fishman Ltd reported no remaining Tango Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Jay A. Fishman Ltd sold 19,000 Tango Therapeutics shares in Q3 2024, an estimated $163K.
  • Jay A. Fishman Ltd first reported a position in Tango Therapeutics in Q4 2022 and held it in 7 quarters.
  • Jay A. Fishman Ltd's Tango Therapeutics position peaked at $191K in Q1 2024.
  • 121 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2024.

Based on Jay A. Fishman Ltd's 13F filing for Q3 2024, filed 30 Oct 2024.